Enhanced Pain Education for Chronic Pain
(PEPO Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to compare two different modes of delivering a self-management program for chronic pain (independently vs. with additional support) on pain-related disability.Participants with chronic musculoskeletal pain will take part in a 10-week online pain self-management program. For the participants in the group with additional support, the intervention will also include two physiotherapist-led sessions and one group session with other participants.The hypothesis is that the results will support that both modes of delivery could be effective, but the self-management program with additional support will be more effective for reducing pain intensity and pain disability compared to the self-management program alone.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
Is enhanced pain education for chronic pain safe for humans?
How is the Pain self-management program different from other treatments for chronic pain?
The Pain self-management program is unique because it focuses on educating patients about pain and empowering them to manage it themselves through a structured, lay-led course. This approach emphasizes understanding pain biology and developing coping strategies, rather than relying solely on medication or medical interventions.25678
What data supports the effectiveness of the treatment Enhanced Pain Education for Chronic Pain?
Who Is on the Research Team?
Jean-Sébastien Roy, PhD
Principal Investigator
Laval University
Are You a Good Fit for This Trial?
This trial is for individuals who have been experiencing musculoskeletal pain for over three months. It's not suitable for those unable to commit to a 26-week study, or with conditions like rheumatoid, inflammatory or neurodegenerative diseases, fibromyalgia, complex regional pain syndrome, or recent corticosteroid injections.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 10-week online pain self-management program, with additional support for some participants including two physiotherapist-led sessions and one group session.
Follow-up
Participants are monitored for changes in pain-related functional limitations and other secondary outcomes at 10 and 26 weeks.
What Are the Treatments Tested in This Trial?
Interventions
- Additional support for self-management program
- Pain self-management program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laval University
Lead Sponsor
Quebec Pain Research Network
Collaborator